Funding for this research was provided by:
American Heart Association (18POST34070059)
Foundation for the National Institutes of Health (1DP2CA195761-01, HL067773)
Received: 25 February 2019
Accepted: 15 August 2019
First Online: 23 September 2019
: R.Z. is a co-founder, consultant and stockholder of Frontier Medicines Corporation. D.K.N. is a co-founder, stock-holder and scientific adviser for Artris Therapeutics and Frontier Medicines Corporation.